GLENN LEVINE to Angioplasty, Balloon, Coronary
This is a "connection" page, showing publications GLENN LEVINE has written about Angioplasty, Balloon, Coronary.
Connection Strength
2.600
-
Editorial commentary: The continuing evolution of primary PCI and clinical guidelines. Trends Cardiovasc Med. 2017 02; 27(2):103-105.
Score: 0.466
-
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv. 2012 Feb 15; 79(3):453-95.
Score: 0.343
-
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol. 2011 Dec 06; 58(24):e44-122.
Score: 0.337
-
Newer pharmacotherapy in patients undergoing percutaneous coronary interventions: a guide for pharmacists and other health care professionals. Pharmacotherapy. 2006 Nov; 26(11):1537-56.
Score: 0.238
-
Low-molecular-weight heparin during percutaneous coronary interventions: rationale, results, and recommendations. Catheter Cardiovasc Interv. 2003 Oct; 60(2):185-93.
Score: 0.192
-
Management of patients undergoing percutaneous coronary revascularization. Ann Intern Med. 2003 Jul 15; 139(2):123-36.
Score: 0.189
-
The role of percutaneous revascularization in the treatment of ischemic heart disease: insights from published reports and randomized clinical trials. Chest. 1997 Sep; 112(3):805-21.
Score: 0.126
-
Use of bare-mounted Palmaz-Schatz stents employing the stent saddle technique on the delivery balloon: a single center experience. Cathet Cardiovasc Diagn. 1997 Aug; 41(4):361-8.
Score: 0.125
-
Impact of diabetes mellitus on percutaneous revascularization (CAVEAT-I). CAVEAT-I Investigators. Coronary Angioplasty Versus Excisional Atherectomy Trial. Am J Cardiol. 1997 Mar 15; 79(6):748-55.
Score: 0.122
-
ACCF/AHA/SCAI 2013 Update of the Clinical Competence Statement on Coronary Artery Interventional Procedures: a Report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (Writing Committee to Revise the 2007 Clinical Competence Statement on Cardiac Interventional Procedures). Catheter Cardiovasc Interv. 2013 Aug 01; 82(2):E69-111.
Score: 0.095
-
Enoxaparin 0.3 mg/kg IV supplement for patients transitioning to PCI after subcutaneous enoxaparin therapy for NSTE ACS: a subgroup analysis from the SYNERGY trial. Catheter Cardiovasc Interv. 2010 May 01; 75(6):928-35.
Score: 0.076
-
Degree of anticoagulation after one subcutaneous and one subsequent intravenous booster dose of enoxaparin: implications for patients with acute coronary syndromes undergoing early percutaneous coronary intervention. J Thromb Thrombolysis. 2004 Jun; 17(3):167-71.
Score: 0.050
-
A novel point-of-care enoxaparin monitor for use during percutaneous coronary intervention. Results of the Evaluating Enoxaparin Clotting Times (ELECT) Study. J Am Coll Cardiol. 2003 Sep 17; 42(6):1132-9.
Score: 0.048
-
Pharmacoinvasive management of acute coronary syndrome in the setting of percutaneous coronary intervention: evidence-based, site- and spectrum-of-care strategies for optimizing patient outcomes in NSTE-ACS. J Invasive Cardiol. 2003 Sep; 15(9):536-53.
Score: 0.048
-
Relationship between heparin anticoagulation and clinical outcomes in coronary stent intervention: observations from the ESPRIT trial. J Am Coll Cardiol. 2003 Feb 05; 41(3):386-93.
Score: 0.046
-
In-hospital costs of coronary stent implantation with and without eptifibatide (the ESPRIT Trial). Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin. Am J Cardiol. 2002 Jan 01; 89(1):61-4.
Score: 0.043
-
Reduction of thrombus burden with eptifibatide in a patient with a non-ST segment elevation acute coronary syndrome. J Invasive Cardiol. 2000 Dec; 12 Suppl D:21D-2D.
Score: 0.039
-
Relationship between renal function and outcomes in high-risk patients with non-ST-segment elevation acute coronary syndromes: results from SYNERGY. Int J Cardiol. 2010 Sep 24; 144(1):36-41.
Score: 0.018